| |
| |
|
| Insider
Information: |
Caruso James V |
| Relationship: |
President and CEO, Dir... |
| City: |
Middleton |
| State: |
WI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
152,895 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$30,694 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
152,895 |
|
|
| Total
Value |
$30,694 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -14.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allos Therapeutics Inc |
ALTH |
Chief Commercial Officer |
2010-03-01 |
103,659 |
2006-06-05 |
0 |
Premium* |
|
|
Cellectar Bioscienc |
CLRB |
President and CEO, Dir... |
2023-12-08 |
49,236 |
2015-11-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2009-03-25 |
4 |
AS |
$7.13 |
$49,209 |
D/D |
(6,900) |
116,373 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2009-03-26 |
4 |
AS |
$7.37 |
$291,206 |
D/D |
(39,500) |
116,373 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2009-03-16 |
4 |
OE |
$3.13 |
$11,268 |
D/D |
3,600 |
119,973 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2009-03-25 |
4 |
OE |
$3.13 |
$21,597 |
D/D |
6,900 |
123,273 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2009-08-03 |
4 |
OE |
$3.13 |
$156,500 |
D/D |
50,000 |
138,873 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2010-02-23 |
4 |
AS |
$7.44 |
$44,378 |
D/D |
(5,968) |
141,159 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2010-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
58,254 |
147,127 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2009-03-26 |
4 |
OE |
$3.13 |
$123,635 |
D/D |
39,500 |
155,873 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2009-03-12 |
4 |
OE |
$3.13 |
$156,500 |
D/D |
50,000 |
166,373 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2009-08-10 |
4 |
OE |
$3.13 |
$267,302 |
D/D |
85,400 |
174,273 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
Chief Commercial Officer |
• – – |
2010-03-01 |
4 |
OE |
$3.13 |
$125,200 |
D/D |
40,000 |
181,159 |
0 |
- |
|
| CLRB |
Cellectar Bioscienc |
President and CEO |
• • – |
2018-03-12 |
4 |
AS |
$1.20 |
$40,705 |
D/D |
(34,000) |
213,548 |
0 |
- |
|
| CLRB |
Cellectar Bioscienc |
President and CEO |
• • – |
2017-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
247,548 |
0 |
- |
|
38 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
